drugset / Trial / NCT03909451

Sotagliflozin Multiple-dose Study in Healthy Chinese Subjects

NCT03909451

Phase 1 Completed 24 enrolled Sanofi
RandomizedSequentialDouble-blindTreatment

Summary

Primary Objective: To assess the safety and tolerability of sotagliflozin after a multiple oral dose administration in Chinese healthy subjects. Secondary Objectives: * To assess the pharmacokinetic (PK) parameters of sotagliflozin after a multiple oral dose administration in Chinese healthy subjects. * To assess the pharmacodynamics (PD) parameters of absolute urinary glucose excretion after a multiple oral dose administration in Chinese healthy subjects.

Timeline

Start
2019-04-28
Primary completion
2019-08-19
Completion
2019-08-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Sotagliflozin Small molecule Oral

Indications